Abstract
Sacral neuromodulation (SNM) is an effective, guidelines supported, third line treatment for overactive bladder (OAB). While the prevalence of OAB is similar between males and females, no studies assess the outcomes of SNM in male patients alone. In this retrospective study, we followed 53 male patients with neurogenic and idiopathic OAB to assess efficacy, personal satisfaction, complications and need for other treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have